Syllable, a Sunnyvale, Calif.-based an AI-powered healthcare services company, raised $28m in Series B funding.
The round was led by Oak HC/FT with participation from Section 32. In conjunction with the funding, Vig Chandramouli, Principal at Oak HC/FT, will join the Syllable Board of Directors.
The company intends to use the funds to scale partnerships with health systems, deploy with payers, and grow the team.
Led by Kobus Jooste, CEO, Syllable has built an AI platform that answers every call received by a hospital and enables automated workflows and self-service options to help patients find and take the correct next step in their healthcare journey. The platform introduces patients to an agent for situations that require a human touch for successful call resolution.
In March 2020, the company launched a COVID-19 assistant, an AI assistant helping health systems deploy automated solutions to address the surge in patient inquiries related to the pandemic. Since its launch, the COVID-19 assistant has expanded to support vaccine distribution, including outbound voice and SMS campaigns.
Since 2017, Syllable’s solutions have been in use by some of the largest and most respected healthcare providers across the United States.